LRMR

3.1402.48%
JS

Jonathan S. Leff

Independent Director

Mr. Jonathan S. Leff, M.B.A. is Director of Elion Therapeutics, Inc. Mr. Leff, serves as Director at Larimar Therapeutics, Inc. since May 28, 2020. Mr. Leff serves as a Member of Board of Managers at Apertura Gene Therapy, LLC. Mr. Leff was an Independent Director of BiomX Inc. from March 15, 2024 until February 9, 2026. He serves on the Board of Adaptive Phage Therapeutics since July 2021. He serves as Head of Clinical Development for Inflammation Disease Biology at Roche Palo Alto, LLC. He serves as Director at Melinta Therapeutics, Inc. since April 20, 2020. Mr. Leff is a Partner of Warburg Management Company, L.P. He is a Partner and Chairman of Deerfield Management Company, L.P. Series C. since April 20, 2020. He joined Deerfield in 2013 and focuses on investments in biotechnology and pharmaceuticals. He serves as Chairman of the Deerfield Institute. He served as General Partner of Warburg, Pincus & Co. since January 2000. He served as the Managing Director at Warburg Pincus LLC and Warburg Pincus Ventures L.P. He joined Warburg Pincus in 1996. He focused on investments in the healthcare sector and leads its investment efforts in biotechnology, pharmaceuticals and related industries in North America. From January 1999 to December 1999, he served as the Vice President of Warburg Pincus and Associate from July 1996 to December 1998. He served as a Consultant at Oliver Wyman Actuarial Consulting, Inc. and Oliver, Wyman & Co. He serves as the Chairman of the Medical Industry Group of the National Venture Capital Association. He serves as Chairman of the Deerfield Institute. He served as Member of the Board of Directors at Biotechnology Innovation Organization. He serves as a Director of Hana Biosciences, Inc. and Jaguar Gene Therapy, LLC. He serves as the Director at Dracen Pharmaceuticals, Inc. He was a Director of Proteon Therapeutics, Inc. since August 2, 2017 until April 15, 2019. He has been a Director of GANIC Pharmaceuticals, Inc. since 2000 and Shire Human Genetic Therapies, Inc. since June 2000. He served as a Director of Allos Therapeutics, Inc. since March 2005. Mr. Leff served as a Director of Inspire Pharmaceuticals, Inc. since July 2007 and National Venture Capital Association since April 7, 2011. He serves on the Board of Directors of Synaptic Pharmaceutical Corp. He has been a Director of Aprecia Pharmaceuticals Company since January 27, 2016. He has been a Director of Lundbeck Research USA, Inc. since August 2001. He served as Director of Larimar Therapeutics, Inc. (formerly Chondrial Therapeutics, Inc.) from December 2016 until May 2020. He served as a Non-Employee Director of Mirum Pharmaceuticals, Inc., since November 2018 till July 2019. He served as a Director of Syros Pharmaceuticals, Inc since January 2016 until June 29, 2016 and Archimedes Pharma. He served as a Director of ReSearch Pharmaceutical Services, Inc. He served as a Director of Nivalis Therapeutics, Inc. from April 2014 to April 27, 2016. He served as a Director of KemPharm, Inc. from June 2014 to March 2015. He served as a Director of Talon Therapeutics, Inc. from June 7, 2010 to January 1, 2013. He served as Director of Sophiris Bio, Inc. (Formerly known as Protox Therapeutics Inc) from November 19, 2010 to November 2012. He served as a Director of Vitalcom Inc. since September 1999. He served as a Director at Melinta Therapeutics, Inc since April 01, 2003. He served as an Independent Director of Neurogen Corporation from April 2004 to July 25, 2008 and Altus Pharmaceuticals Inc. from May 2004 to December 31, 2008. He served as a Director of Alita Pharmaceuticals, Inc. from 2006 to 2008. He served as an Independent Director of Audentes Therapeutics, Inc. since November 2014 until July 2016. He served as a Director of Neocrin Company. He served as a Director at AveXis, Inc since October 2014 until May 30, 2017. He served as a Director of InterMune, Inc. from January 2000 to November 26, 2012. He served as a Director of Zymogenetics, Inc. from November 2000 to October 8, 2010. He served as Director at Protara Therapeutics, Inc. He served as a Director of Triangle Pharmaceuticals, Inc. since August 2001. He served as an Independent Director of Sunesis Pharmaceuticals, Inc. from 1999 to February 3, 2009. He served as a Director and a Member of Emerging Companies Section Governing Board at Biotechnology Industry Organization (BIO). He served as a Director of Visible Genetics Inc. since July 1999. He currently serves on the board of directors of ARS Pharmaceuticals, Inc., a publicly traded biopharmaceutical company. He is a Member of several not-for-profit Boards, including the Spinal Muscular Atrophy Foundation, Friends of Cancer Research and the Columbia University Medical Center Board of Advisors. Mr. Leff serves as a Director at Advanced Medicine Partners. Mr. Leff holds an M.B.A. from the Stanford University Graduate School of Business, an A.B. in Government from Harvard University and M.S. in Biotechnology from Johns Hopkins University.

Positions